The Johns Hopkins Vasculitis Center is a specialty care and research center focused on rare diseases. The goal of the JHVC Research Programs is to provide personalized medicine. This center is currently recruiting patients to help advance the understanding of vasculitis diseases. If you’re interested in learning more about our research programs, head to www.hopkinsvasculitis.org/
Yoga, Tai Chi, meditation, and acupuncture are some of the mind and body practices that have been found to be beneficial for those with arthritis. Always discuss with your doctor before starting these activities. In this video, Dr. Dana DiRenzo discusses the different mind and body practices that may be beneficial to a patient with psoriatic arthritis.
There are many herbs and supplements that have been found to be beneficial in curbing arthritis pain, however, you should always be mindful of the potential risks and side effects. In this video, Dr. Dana DiRenzo discusses the different complementary and alternative medicines that may be beneficial to a patient with psoriatic arthritis.
Established in the spring of 2015, the Johns Hopkins Lyme Disease Research Center is the first research center in a major department of medicine in the United States focused on patient-based research in all aspects of Lyme disease. The mission of the Center is to understand and urgently address the varied manifestations of Lyme disease and translate our pioneering multi-disciplinary research into improved patient care, education, and health outcomes. By improving the understanding of the causes and complex biologic processes of Lyme disease, we strive for a future where more accurate diagnoses and effective treatments bring new hope to Lyme disease patients and their families.
Dr. Eleni Tiniakou discusses finding specific T cells in scleroderma. It is believed these T cells play a major role initiating the disease of scleroderma.
In this highlight of research presented at the American College of Rheumatology conference in San Diego, Dr. Cappelli discusses research related to cancer immunotherapy and inflammatory arthritis.
A new type of therapy called Immunotherapy, is used to treat cancers. It’s been observed that Immunotherapy could lead to an over-activation of the immune system. In Rheumatology we’re seeing an increase in arthritis driven by this activation of the immune system. Dr. Cappelli discusses the questions she and her oncologist colleagues have about why this happens and how do we best evaluate and treat these patients.
There has been some speculation on whether or not biologic medications can increase a patient’s risk of getting cancer in the long run. Dr. Laura Cappelli from the Arthritis Center discusses these risks as well as the research studies behind them.
Nurse Vicky Ruffing and Dr. Erika Darrah speak about the existing barriers of immunizations, as well as why it is so important for people with a rheumatic disease to keep up to date with their vaccines.